Funding

Bone Solutions closed a funding round for a total of >US $1.7MM, and affirmed an additional $1.65MM commitment from Next Health, its distribution partner.

Spinal Simplicity closed a financing round with an investment from Nueterra Capital. Funds will support U.S. launch of the Minuteman fusion device to treat low back pain.

Xtant Medical was awarded state grants totaling US $0.15MM to support growth at Bacterin's orthobiologic processing facility. 

Tyber Medical was awarded a US $362,500, ten-year loan from the Pennsylvania Industrial Development Authority to purchase equipment for in-house fabrication.

Nanovis received an NIH grant supporting pre-clinical studies of FortiCore® deeply-porous interbody fusion devices, enhanced with nanotube technology. 

Bone Biologics completed a US $5.75MM funding round to support development of a bone graft substitute for initial focus on spinal fusion.

Regentis Biomaterials closed a US $15MM Series D investment round. Funds will primarily support a pivotal U.S. clinical trial of GelrinC®, a cell-free implant for the treatment of articular knee cartilage injuries.

Ellipse Technologies withdrew its plans for a US $75MM initial public offering, filed in 4Q15, in light of its pending acquisition by NuVasive.

OsteoVantage was awarded a US $0.15MM SBIR Phase I grant. Funds will support enhancements to INDOS™, a spinal instrumentation system that employs electroactive pedicle screws to encourage posterolateral fusion.

CartiHeal completed a US $15MM financing round. Funds will support ongoing manufacturing scale-up, EU product commercialization in 2017 and clinical studies in new therapeutic areas for Agili-C™ cartilage regeneration technology.